logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Cecilia Carpio

vall d'hebron university hospital
H指数:24
被引数:2,008

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma

氟达拉滨暴露对大B细胞淋巴瘤患者CAR T细胞疗效的影响

Blood Advances
IF7.1
2026-06-120
OAAI
Mario Andrés Sánchez-Salinas; Javier Varela-González-Aller; Gloria Iacoboni; Víctor Navarro; Iñaki Troconiz; Cecilia Carpio; Carla Alonso-Martínez; Maria-Josep Carreras-Soler; Anna Farriols-Danes; María Guerra-González; Alfredo Rivas-Delgado; Lucas Rivera; Samantha Feijoo; Francesc Bosch; Carolina Valdivia; Marta Miarons; Pere Barba
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy

迈向个性化淋巴细胞清除：接受CAR T细胞疗法的患者群体药代动力学氟达拉滨模型

Pharmaceutics 2025, Vol. 17, Page 1592
IF5.5
2025-12-100
OA
Javier Varela-González-Aller; Mario Andrés Sánchez-Salinas; Iñaki Troconiz; Gloria Iacoboni; Carla Alonso-Martínez; Maria-Josep Carreras-Soler; Cecilia Carpio; Anna Farriols-Danes; María Guerra-González; Alfredo Rivas-Delgado; Lucas Rivera Sanchez; Samantha Feijoo; Carolina Valdivia; Pere Barba; Marta Miarons
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy

大B细胞淋巴瘤患者接受CAR T细胞治疗时的患者选择与治疗结果随时间的变化

Bone Marrow Transplantation
IF5.2
2025-09-300
PRE
Anna Torrent; Mireia Morgades; Gloria Iacoboni; Juan Luis Reguera; Mi Kwon; Lucia López Corral; Rafael Hernani; Valentín Ortiz-Maldonado; Jaime Sanz; Ana Carolina Caballero Gonzalez; Luisa Guerra; José María Sánchez Pina; Alberto Mussetti; Alejandro Martin Garcia-Sancho; Mariana Bastos-Oreiro; Javier Delgado; Cecilia Carpio; Juan-Manuel Sancho; Antonio Pérez-Martinez; Pere Barba
Use of Dasatinib for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome After Axicabtagene Ciloleucel Infusion: A Case Report

使用达沙替尼治疗阿西美妥昔细胞输注后难治性免疫效应细胞相关神经毒性综合征：一例病例报告

EUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
2025-09-010
PRE
Llata-Ortega, Jaime; Pau-Parra, Alba; Alonso-Martinez, Carla; Garcia-Roche, Alejandra; Carpio, Cecilia; Barba, Pere; Murillo-Florez, Ilda; Iacoboni, Gloria
Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy

通过血清神经丝蛋白评估接受CD19靶向CAR T细胞疗法的ICANS患者中与严重程度相关的神经轴突损伤

European Journal of Neurology
IF3.9
2025-08-050
OAAI
Andreu Vilaseca; Helena Ariño; Gloria Iacoboni; Samantha Feijóo; Ana Zabalza; Nicolás Fissolo; María Jesús Arévalo; Cecilia Carpio; Mario Sánchez; Mar Tintoré; Manuel Comabella; Xavier Montalban; Pere Barba; Ángela Vidal-Jordana
A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial

一项Ib/II期临床试验，将brentuximab vedotin与环磷酰胺、丙卡巴肼、泼尼松、依托泊苷和米托蒽醌（BrEPEM）联合用于未经治疗的老年经典型霍奇金淋巴瘤患者：一项多中心GELTAMO试验

British Journal of Haematology
IF3.8
2025-07-250
PRE
Cecilia Carpio; Fátima de la Cruz-Vicente; Ramon García-Sanz; Izaskun Zeberio; Cristina Barrenetxea; Eva Domingo-Domenech; Mariana Bastos; Araceli Rubio Martinez; Pilar Gómez-Prieto; Antonia Rodriguez; Maria Casanova; Antonia Cladera-Serra; Javier Nuñez Cespedes; Carmen Martínez; Miriam Moreno-Velázquez; Eduardo Garcia-Galea; Pau Abrisqueta; Francesc Bosch
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders

SARS-CoV-2感染对B细胞淋巴增殖性疾病患者双特异性抗体治疗的影响

Blood Advances
IF7.1
2025-05-260
OAAI
Ángel Serna; Víctor Navarro; Moraima Jiménez; Josu Iraola-Truchuelo; Marc Bosch; Cristina García; Anna Falcó; Adaia Albasanz; Isabel Ruiz-Camps; Cristina Andrés; Andrés Antón; Juliana Esperalba; Ainara Ferrero; Tomás García; Cecilia Carpio; Marta Crespo; Gloria Iacoboni; Ana Marín-Niebla; Francesc Bosch; Pau Abrisqueta
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (vol 6, pg 528, 2025)

奥德诺奈特单抗单药治疗复发/难治性弥漫性大B细胞淋巴瘤：ELM-2试验第二阶段（vol 6, pg 528, 2025）的主要有效性和安全性分析

NATURE CANCER
IF28.5
2025-04-160
OA
Kim, Won Seog; Kim, Tae Min; Cho, Seok-Goo; Jarque, Isidro; Iskierka-Jazdzewska, Elzbieta; Poon, Li Mei; Prince, H. Miles; Zhang, Huilai; Cao, Junning; Zhang, Mingzhi; Tessoulin, Benoit; Oh, Sung Yong; Lim, Francesca; Carpio, Cecilia; Tan, Tran-Der; Ayyappan, Sabarish; Gutierrez, Antonio; Cai, Jingxian; Ufkin, Melanie; Shariff, Saleem; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Walewski, Jan
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy

结外受累的大B细胞淋巴瘤的位点特异性分析揭示了嵌合抗原受体T细胞疗法的独特疗效

LEUKEMIA
IF13.4
2025-04-010
PRE
Iacoboni, Gloria; Rejeski, Kai; Navarro, Victor; van Meerten, Tom; Rampotas, Alex; Martin-Lopez, Ana Africa; Bastos, Mariana; Benzaquen, Ana; Reguera-Ortega, Juan Luis; Carpio, Cecilia; Roddie, Claire; Lopez-Corral, Lucia; Delgado-Serrano, Javier; Landwehr, Maria; Stock, Sophia; de Tena, Pablo Silva; Abrisqueta, Pau; de Boer, Janneke; Martin Garcia-Sancho, Alejandro; Hernani, Rafael; Kwon, Mi; Subklewe, Marion; O'Reilly, Maeve; Barba, Pere
Enhancing CAR-T Cell Therapy for Non-Hodgkin Lymphoma through Gut Microbiota and Butyrate

通过肠道微生物组和丁酸盐增强非霍奇金淋巴瘤的CAR-T细胞疗法

BLOOD
IF23.1
2024-11-050
PRE
Garcia-Vicente, Roberto; Garcia, Alba Rodriguez; Ancos-Pintado, Raquel; Barea, Andres Arroyo; Ortega-Hernandez, Adriana; Bragado-Garcia, Irene; Castellano, Eva; Ortiz-Ruiz, Alejandra; Navarro-Aguadero, Miguel Angel; Modrego, Javier; Leivas, Alejandra; Sanchez-Pina, Jose; Fernandez, Rafael Alonso; Hernandez-Sanchez, Maria; Fulciniti, Mariateresa; Carpio, Cecilia; Barba, Pere; Carbonell, Diego; Kwon, Mi; Bastos-Oreiro, Mariana; Garcia-Sancho, Alejandro Martin; Ubieto, Ana Jimenez; Valeri, Antonio; Gomez-Garre, Dulcenombre; Martinez-Lopez, Joaquin; Linares, Maria
Treatment Duration and Risk of Fatal Infections in Patients with B-Cell Non-Hodgkin Lymphoma Achieving Complete Response with Odronextamab

奥德诺克单抗（Odronextamab）治疗B细胞非霍奇金淋巴瘤患者完全缓解后，治疗持续时间与致命性感染风险的关系

BLOOD
IF23.1
2024-11-050
PRE
von Keudell, Gottfried; Hawkes, Eliza A.; Carpio, Cecilia; Topp, Max S.; Shen, Biyi; Li, Jingjin; Hearnden, Claire; Shariff, Saleem; Mohamed, Hesham; Ambati, Srikanth; Chaudhry, Aafia; Ayyappan, Sabarish
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells
HEMASPHERE
IF14.6
2024-06-260
OAAI
Iacoboni, Gloria; Sanchez-Salinas, Mario A.; Rejeski, Kai; Martin-Lopez, Ana a.; Kwon, Mi; Navarro, Victor; Jalowiec, Katarzyna A.; Hernani, Rafael; Reguera-Ortega, Juan L.; Gallur, Laura; Blumenberg, Viktoria; Herrero-Garcia, Maria; Roddie, Claire; Benzaquen, Ana; Delgado-Serrano, Javier; Bailen, Rebeca; Carpio, Cecilia; Amat, Paula; Lopez-Corral, Lucia; Martin-Martin, Lourdes; Bastos, Mariana; Subklewe, Marion; O'Reilly, Maeve; Barba, Pere
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
NATURE COMMUNICATIONS
IF15.7
2023-03-139
OAAI
Moreno, Victor; Vieito, Maria; Sepulveda, Juan Manuel; Galvao, Vladimir; Hernandez-Guerrero, Tatiana; Doger, Bernard; Saavedra, Omar; Carlo-Stella, Carmelo; Michot, Jean-Marie; Italiano, Antoine; Magagnoli, Massimo; Carpio, Cecilia; Pinto, Antonio; Sarmiento, Rafael; Amoroso, Barbara; Aronchik, Ida; Filvaroff, Ellen; Hanna, Bishoy; Wei, Xin; Nikolova, Zariana; Brana, Irene
Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

嵌合抗原受体T细胞治疗对侵袭性b细胞淋巴瘤患者巨细胞病毒复制的影响

TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2022-12-0129
OAAI
Marquez-Algaba, Ester; Iacoboni, Gloria; Pernas, Berta; Esperalba, Juliana; Los Arcos, Ibai; Navarro, Victor; Monforte, Arnau; Beas, Francisco; Albasanz-Puig, Adaia; Carpio, Cecilia; Barba, Pere; Ruiz-Camps, Isabel
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma
ANNALS OF HEMATOLOGY
IF2.4
2022-11-124
PRE
Martinez, Carmen; Espeso de Haro, Manuel; Romero, Samuel; Gutierrez, Antonio; Domingo-Domenech, Eva; Gonzalez-Rodriguez, Ana P.; Zeberio, Izaskun; Paz Martinez-Badas, Maria; Rodriguez-Izquierdo, Antonia; Carpio, Cecilia; Bastos-Oreiro, Mariana; Angel Hernandez-Rivas, Jose; Vallansot, Rolando; Kelleher, Nicholas; Diaz-Galvez, Francisco J.; Torrado, Tamara; Pereira, Arturo; Garcia-Sanz, Ramon
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
HEMATOLOGICAL ONCOLOGY
IF3.9
2022-10-312
OAAI
Carlo-Stella, Carmelo; Zinzani, Pier Luigi; Sureda, Anna; Araujo, Luis; Casasnovas, Olivier; Carpio, Cecilia; Yeh, Su-Peng; Bouabdallah, Krimo; Cartron, Guillaume; Kim, Won Seog; Cordoba, Raul; Koh, Youngil; Re, Alessandro; Alves, Daniela; Chamuleau, Martine; Le Gouill, Steven; Lopez-Guillermo, Armando; Moreira, Ilidia; van der Poel, Marjolein W. M.; Abbadessa, Giovanni; Meng, Robin; Ji, Ran; Lepine, Lucie; Saleem, Rao; Ribrag, Vincent

研究方向

暂未获取到该数据
G
Gloria Iacoboni
H 指数:28论文数:191被引数:3,802
F
Francesc Bosch
H 指数:59论文数:495被引数:1.5万
P
Pere Barba
H 指数:41论文数:290被引数:6,375
P
Pau Abrisqueta
H 指数:37论文数:323被引数:5,136
M
Marta Crespo
H 指数:23论文数:113被引数:4,469
M
Mariana Bastos‐Oreiro
H 指数:20论文数:245被引数:1,576
V
Vı́ctor Navarro
H 指数:27论文数:152被引数:2,561
J
Josep Castellví
H 指数:43论文数:225被引数:5,903
M
Mi Kwon
H 指数:32论文数:330被引数:3,827
M
Mario Sánchez-Salinas
H 指数:5论文数:26被引数:177